1.
MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome
by Wang, Kunning Kunning
Gut, 2015-07-23, Vol.65 (10), p.1619-1631
2.
Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis
by Hao, Ning-Bo
Cancer letters, 2015, Vol.361 (1), p.57-66
3.
Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression
by Tang, Dong
Tumor biology, 2015-09-01, Vol.37 (2), p.1889-1899
4.
Gastric schwannoma: a clinicopathologic study of 51 cases and critical review of the literature
by Voltaggio, Lysandra, MD
Human pathology, 2012, Vol.43 (5), p.650-659
5.
Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice
by Ernst, Matthias
Nature medicine, 2002-10, Vol.8 (10), p.1089-1097
6.
MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1
by Yan, Jiang
Medical oncology (Northwood, London, England), 2014-02-11, Vol.31 (3), p.879-879
7.
Gastric neuroendocrine neoplasms and related precursor lesions
by La Rosa, Stefano
Journal of Clinical Pathology, 2014-11, Vol.67 (11), p.938-948
8.
miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells
by Feng, Li
Medical oncology (Northwood, London, England), 2011-01-25, Vol.29 (2), p.856-863
9.
Harmine induces apoptosis and inhibits tumor cell proliferation, migration and invasion through down-regulation of cyclooxygenase-2 expression in gastric cancer
by Zhang, Hao
Phytomedicine (Stuttgart), 2014-02-15, Vol.21 (3), p.348-355
10.
Early or late antibiotic intervention prevents Helicobacter pylori -induced gastric cancer in a mouse model
by Zhang, Songhua
Cancer letters, 2014, Vol.355 (1), p.106-112
11.
Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma
by Lin, Ting
Medical oncology (Northwood, London, England), 2011-02-20, Vol.29 (2), p.878-885
12.
The Acid-Secreting Parietal Cell as an Endocrine Source of Sonic Hedgehog During Gastric Repair
by Engevik, Amy C
Endocrinology (Philadelphia), 2013-12, Vol.154 (12), p.4627-4639
13.
Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance
by Zhang, Yuanyuan
Medical oncology (Northwood, London, England), 2009-07-14, Vol.27 (3), p.685-689
14.
Small gastrointestinal stromal tumor in the stomach: identification of precursor for clinical gastrointestinal stromal tumor using c-kit and α -smooth muscle actin expression
by Mikami, Tetuo, MD
Human pathology, 2013, Vol.44 (12), p.2628-2635
15.
Aquaporin 5 promotes the proliferation and migration of human gastric carcinoma cells
by Huang, Yong-Hong
Tumor biology, 2013-02-23, Vol.34 (3), p.1743-1751
16.
Evidence that gastric pit dysplasia-like atypia is a neoplastic precursor lesion
by Agoston, Agoston T., MD, PhD
Human pathology, 2014, Vol.45 (3), p.446-455
17.
miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer
by Wen, Dacheng
Tumor biology, 2013-01-09, Vol.34 (2), p.793-803
18.
Anti-secretory and cyto-protective effects of chebulinic acid isolated from the fruits of Terminalia chebula on gastric ulcers
by Mishra, Vaibhav
Phytomedicine (Stuttgart), 2013-04-15, Vol.20 (6), p.506-511
19.
Clinical Significance of Stanniocalcin 2 as a Prognostic Marker in Gastric Cancer
by Yokobori, Takehiko
Annals of surgical oncology, 2010-04-27, Vol.17 (10), p.2601-2607
20.
Role and clinicopathologic significance of CXC chemokine ligand 16 and chemokine (C-X-C motif) receptor 6 expression in gastric carcinomas
by Xing, Ya-nan
Human pathology, 2012-12, Vol.43 (12), p.2299-2307
